Enhanced transdermal delivery of triprolidine from the ethylene-vinyl acetate matrix

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 54, Issue 3, 2002, Pages 325-328

  Shin, Sang Chul ^a   Lee, Hyun Jin ^a  

^a Chonnam National University   (South Korea)

Author keywords

Ethylene vinyl acetate; Matrix; Penetration enhancer; Skin permeation; Transdermal delivery; Triprolidine

Indexed keywords

DECANOIC ACID; DIETHYLENE GLYCOL; ETHYLENE VINYL ACETATE COPOLYMER; GLYCOL; LAURIC ACID; MYRISTIC ACID; POLIDOCANOL; POLYOXYETHYLENE OLEYL ETHER; POLYOXYETHYLENE STEARYL ETHER; TETRAETHYLENE GLYCOL; TRIPROLIDINE; UNCLASSIFIED DRUG; ETHYLENEVINYLACETATE COPOLYMER; POLYVINYL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; MALE; MOUSE; NONHUMAN; SKIN PERMEABILITY; STRATUM CORNEUM; ANIMAL; DRUG EFFECT; INSTITUTE FOR CANCER RESEARCH MOUSE; INTRADERMAL DRUG ADMINISTRATION; METABOLISM; METHODOLOGY; PERMEABILITY; SKIN;

ADMINISTRATION, CUTANEOUS; ANIMALS; DRUG DELIVERY SYSTEMS; MALE; MICE; MICE, INBRED ICR; PERMEABILITY; POLYVINYLS; SKIN; TRIPROLIDINE;

EID: 0036849569     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(02)00088-7     Document Type: Article

References (18)

1. Barry B.W. Dermatological Formulations: Percutaneous Absorption. 1983;160-172 Marcel Dekker, New York.
2. Waranis P., Sloan K.B. Effect of vehicle and prodrug properties and their interactions on the delivery of 6-mercaptopurine through skin: Bisacyloxymethyl-6-mercaptopurine prodrugs. J. Pharm. Sci. 76:1987;587-595.
3. Kondo S., Sugimoto I. Enhancement of transdermal delivery by superfluous thermodynamic potential. I. Thermodynamic analysis of nifedipine transport across the lipoidal barrier. J. Pharmacobio-Dyn. 10:1987;587-594.
4. Brucks R., Nanavaty M., Jung D., Siegel F. The effect of ultrasound on the in vitro penetration ibuprofen through human epidermis. Pharm. Res. 6:1989;679-701.
5. Chien Y.W. Novel Drug Delivery Systems: Fundamentals, Developmental Concepts and Biomedical Assessments. 1982;149-217 Marcel Dekker, New York.
6. Shin S.C., Lee H.J. Controlled release of triprolidine using ethylene-vinyl acetate membrane and matrix system. Eur. J. Pharm. Biopharm. 54:2002;201-206.
7. Shin S.C., Yoon M.K. Application of TPX polymer membranes for the controlled release of triprolidine. Int. J. Pharm. 232:2002;131-137.
8. Shin S.C., Choi J.S. Enhanced bioavailability of triprolidine from the transdermal TPX matrix. Int. J. Pharm. 234:2002;67-73.
9. Shin S.C., Kim J., Yoon M.K., Oh I.J., Choi J.S. Transdermal delivery of triprolidine using TPX polymer membrane. Int. J. Pharm. 235:2002;141-147.
10. Miyazaki S., Ishii K., Takada M. Controlled release of anticancer agents through ethylene-vinyl acetate copolymer membranes. Yakuzaigaku. 42:1983;259.
11. Durrhein H., Flynn G.L., Higuchi W.I., Behl C.R. Permeation of hairless mouse skin: Experimental methods and comparison with human epidermis permeation by alkanols. J. Pharm. Sci. 69:1980;781.
12. Behl C.R., Linn E.E., Flynn G.L., Pierson C.L., Higuchi W.I., Ho N.F.O. Permeation of skin and Escher by antiseptics. I. Baseline studies with phenol. J. Pharm. Sci. 72:1983;391-396.
13. Aungst B.J., Rogers J.J., Shegter E. Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides. Int. J. Pharm. 33:1986;225-234.
14. Aungst B.J., Rogers N.J. Comparison of the effects of various transmucosal absorption promoters on buccal insulin delivery. Int. J. Pharm. 53:1989;227-235.
15. Kadir R., Stempler D., Liron Z., Cohen S. Penetration of adenosine into excised human skin from binary vehicles. J. Pharm. Sci. 77:1988;409-413.
16. Higuchi W.I., Kim Y.H., Ghanem A.H., Abraham W., Herron J.N. Mechanistic studies of skin permeation enhancement employing the normal alkanols. Proc. Int. Symp. Controlled Release Bioact. Mater. 1992;137-138.
17. Leopoid C.S., Lippold B.C. Enhancing effects of lipophilic vehicles on skin penetration of methyl nicotinate in vivo. J. Pharm. Sci. 84:1995;195-198.
18. Bach M., Lippold B.C. Percutaneous penetration enhancement and its quantification. Eur. J. Pharm. Biopharm. 46:1998;1-13.